Corcept Therapeutics Incorporated
CORT
$69.57
$0.751.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 71.07% | -33.17% | -34.88% | 33.04% | 27.83% |
| Total Depreciation and Amortization | 1.52% | 0.43% | -7.82% | 152.02% | 10.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -100.82% | -40.15% | 645.26% | -10.79% | -155.11% |
| Change in Net Operating Assets | 137.53% | -228.63% | -38.24% | 285.77% | 198.22% |
| Cash from Operations | 756.84% | -91.35% | -19.68% | 79.25% | 73.38% |
| Capital Expenditure | 45.19% | 14.05% | 92.60% | -293.03% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,388.36% | 95.23% | -51.50% | 29.07% | -563.17% |
| Cash from Investing | 2,311.51% | 95.07% | -46.15% | 26.84% | -567.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 262.08% | 42.71% | 6.70% | -29.90% | 91.65% |
| Repurchase of Common Stock | -166.87% | -519.30% | 70.10% | -333.66% | -141.35% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -158.61% | -772.11% | 78.36% | -881.02% | -295.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 134.15% | -293.25% | -210.61% | 141.12% | -249.04% |